Alessandro Gronchi
#176,898
Most Influential Person Across History
Researcher
Alessandro Gronchi's AcademicInfluence.com Rankings
Alessandro Gronchicomputer-science Degrees
Computer Science
#6410
Historical Rank
Machine Learning
#1876
Historical Rank
Artificial Intelligence
#2135
Historical Rank
Database
#3329
Historical Rank
Download Badge
Computer Science
Alessandro Gronchi's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Alessandro Gronchi Influential?
(Suggest an Edit or Addition)Alessandro Gronchi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. (2005) (773)
- Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2014) (642)
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (624)
- NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. (2007) (623)
- Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2015) (425)
- Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. (2007) (420)
- Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. (2009) (396)
- Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group (2016) (367)
- Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution (2004) (356)
- Malignant peripheral nerve sheath tumors (2006) (351)
- Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution. (2003) (338)
- A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient. (2004) (337)
- Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. (2017) (332)
- Desmoid-Type Fibromatosis: A Front-Line Conservative Approach to Select Patients for Surgical Treatment (2009) (332)
- Rhabdomyosarcoma in adults (2003) (276)
- Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. (2016) (270)
- Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control (2010) (264)
- Imatinib mesylate in chordoma (2004) (262)
- Outcome prediction in primary resected retroperitoneal soft tissue sarcoma: histology-specific overall survival and disease-free survival nomograms built on major sarcoma center data sets. (2013) (255)
- Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2012) (254)
- Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells. (2010) (253)
- An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG) (2017) (250)
- Extremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution: Local Control Directly Impacts Survival (2010) (250)
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (244)
- Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. (2005) (243)
- Surgery of Residual Disease Following Molecular-targeted Therapy With Imatinib Mesylate in Advanced/Metastatic GIST (2007) (242)
- On Pathology (1815) (235)
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (230)
- Phase II study of imatinib in advanced chordoma. (2012) (230)
- Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis (2001) (224)
- Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (216)
- Chordoma: Natural History and Results in 28 Patients Treated at a Single Institution (2003) (210)
- Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. (2005) (204)
- Technical Considerations in Surgery for Retroperitoneal Sarcomas: Position Paper from E-Surge, a Master Class in Sarcoma Surgery, and EORTC–STBSG (2012) (199)
- Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience (2013) (199)
- The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients. (2020) (194)
- Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial (2018) (192)
- Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine (2020) (187)
- Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. (2015) (184)
- Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect. (2011) (182)
- Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas. (2012) (181)
- Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution (2011) (179)
- Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three‐grade system (2005) (177)
- Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST). (2009) (176)
- Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought (2013) (171)
- NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. (2019) (170)
- High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria. (2009) (170)
- Chordoma of the Mobile Spine and Sacrum: A Retrospective Analysis of a Series of Patients Surgically Treated at Two Referral Centers (2009) (166)
- Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial. (2020) (166)
- Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors (2009) (165)
- Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. (2012) (157)
- Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection (2015) (150)
- Response to imatinib plus sirolimus in advanced chordoma. (2009) (149)
- CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence (2013) (148)
- Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (147)
- Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients? (2010) (146)
- Therapeutic Consequences from Molecular Biology for Gastrointestinal Stromal Tumor Patients Affected by Neurofibromatosis Type 1 (2008) (146)
- Myxoid/round cell and pleomorphic liposarcomas (2007) (145)
- Prognostic Effect of Re-Excision in Adult Soft Tissue Sarcoma of the Extremity (2006) (144)
- Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group (2017) (141)
- Molecular and Biochemical Analyses of Platelet-Derived Growth Factor Receptor (PDGFR) B, PDGFRA, and KIT Receptors in Chordomas (2006) (137)
- Telomere maintenance mechanisms in liposarcomas: association with histologic subtypes and disease progression. (2006) (135)
- Retroperitoneal soft tissue sarcomas (2004) (135)
- Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials. (2014) (134)
- Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma (2009) (133)
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (131)
- Natural History of Imatinib-naive GISTs: A Retrospective Analysis of 929 Cases With Long-term Follow-up and Development of a Survival Nomogram Based on Mitotic Index and Size as Continuous Variables (2011) (125)
- Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study). (2014) (124)
- Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. (2015) (123)
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. (2012) (122)
- Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. (2015) (121)
- Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis (2017) (120)
- Gastrointestinal Stromal Tumor of the Rectum: Results of Surgical and Multimodality Therapy in the Era of Imatinib (2013) (119)
- Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. (2009) (117)
- Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis (2004) (116)
- Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm--a position paper from the Italian and the French Sarcoma Group. (2014) (116)
- Adult-type soft tissue sarcomas in pediatric-age patients: experience at the Istituto Nazionale Tumori in Milan. (2005) (115)
- Mode of action of trabectedin in myxoid liposarcomas (2014) (115)
- The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial. (2019) (111)
- Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients (2006) (111)
- Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Tr (2017) (110)
- Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. (2016) (107)
- Sunitinib malate in solitary fibrous tumor (SFT). (2012) (106)
- Soft Tissue and Visceral Sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii102, 2014) (2015) (104)
- Erratum to: Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group (2016) (104)
- Post‐relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans‐Atlantic RPS Working Group (2017) (103)
- Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. (2020) (100)
- Soft tissue sarcoma nomograms and their incorporation into practice (2017) (98)
- Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): Interim analysis of a randomised phase III trial (2007) (97)
- Phase II study on lapatinib in advanced EGFR-positive chordoma. (2013) (95)
- Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications (2017) (94)
- Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors. (2015) (94)
- Epithelioid sarcoma in children and adolescents (2006) (94)
- Surgical Technique, Morbidity, and Outcome of Primary Retroperitoneal Sarcoma Involving Inferior Vena Cava (2012) (94)
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study (2021) (93)
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study (2021) (93)
- Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions (2018) (92)
- Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas. (2010) (91)
- The prognostic impact of dedifferentiation in retroperitoneal liposarcoma (2008) (91)
- Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group. (2016) (89)
- Desmoid-Type Fibromatosis and Pregnancy: A Multi-institutional Analysis of Recurrence and Obstetric Risk (2014) (89)
- Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma (2015) (89)
- External Beam Radiation Therapy for Resectable Soft Tissue Sarcoma: A Systematic Review and Meta-Analysis (2017) (88)
- Histology‐specific nomogram for primary retroperitoneal soft tissue sarcoma (2010) (87)
- Tumor response assessment by modified Choi criteria in localized high‐risk soft tissue sarcoma treated with chemotherapy (2012) (87)
- Corrections to "Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2018) (86)
- Sunitinib Malate and Figitumumab in Solitary Fibrous Tumor: Patterns and Molecular Bases of Tumor Response (2010) (85)
- Alveolar Soft Part Sarcoma: Clinical Presentation, Treatment, and Outcome in a Series of 33 Patients at a Single Institution (2010) (84)
- Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma: A Report From the Transatlantic RPS Working Group (2017) (84)
- p15INK4b, p14ARF, and p16INK4a inactivation in sporadic and neurofibromatosis type 1-related malignant peripheral nerve sheath tumors. (2003) (84)
- External validation of a multi‐institutional retroperitoneal sarcoma nomogram (2016) (83)
- Epithelioid Sarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution (2007) (83)
- Meta‐analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid‐type fibromatosis (2017) (82)
- PDGFRA, PDGFRB, EGFR, and downstream signaling activation in malignant peripheral nerve sheath tumor. (2009) (81)
- Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis (2007) (81)
- Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group. (2014) (80)
- Solitary fibrous tumor of all sites: outcome of late recurrences in 14 patients (2013) (80)
- STRASS (EORTC 62092): A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma. (2019) (79)
- Imatinib in advanced chordoma: A retrospective case series analysis. (2015) (76)
- Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper (2014) (75)
- Activity of sunitinib in extraskeletal myxoid chondrosarcoma. (2014) (75)
- Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP) (2015) (75)
- High-grade Sarcomatous Overgrowth in Solitary Fibrous Tumors: A Clinicopathologic Study of 10 Cases (2012) (75)
- Dermatofibrosarcoma protuberans‐derived fibrosarcoma: Clinical history, biological profile and sensitivity to imatinib (2011) (74)
- Surgical treatment of locally recurrent rectal carcinoma (1997) (72)
- Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (71)
- Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network (2020) (70)
- Quadruple-Negative GIST Is a Sentinel for Unrecognized Neurofibromatosis Type 1 Syndrome (2016) (69)
- Resectable extra-pleural and extra-meningeal solitary fibrous tumours: A multi-centre prognostic study. (2016) (69)
- Aggressive fibromatosis in children and adolescents (2009) (68)
- Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group (2021) (68)
- Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall. (2013) (68)
- Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers (2016) (68)
- Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (2020) (67)
- Carney triad: case report and molecular analysis of gastric tumor. (2005) (67)
- Response to chemotherapy of solitary fibrous tumour: a retrospective study. (2013) (67)
- Delaying surgery for patients with a previous SARS-CoV-2 infection (2020) (66)
- Denosumab treatment of inoperable or locally advanced giant cell tumor of bone - Multicenter analysis outside clinical trial. (2018) (66)
- Extremity Soft Tissue Sarcoma: Adding to the Prognostic Meaning of Local Failure (2007) (66)
- Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas) (2019) (64)
- Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial Sarcoma (2004) (64)
- Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis (2017) (64)
- c-Kit/PDGFRA Gene Status Alterations Possibly Related to Primary Imatinib Resistance in Gastrointestinal Stromal Tumors (2007) (63)
- Imatinib failure-free survival (IFS) in patients with localized gastrointestinal stromal tumors (GIST) treated with adjuvant imatinib (IM): The EORTC/AGITG/FSG/GEIS/ISG randomized controlled phase III trial. (2013) (63)
- Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new (2017) (63)
- Clinical, Pathological and Surgical Characteristics of Duodenal Gastrointestinal Stromal Tumor and Their Influence on Survival: A Multi-Center Study (2012) (62)
- Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm-a position paper from the Italian and the French Sarcoma Group. (2014) (62)
- Desmoid-Type Fibromatosis: Evolving Treatment Standards. (2016) (61)
- KIT, PDGFRA, and BRAF Mutational Spectrum Impacts on the Natural History of Imatinib-naive Localized GIST: A Population-based Study (2015) (61)
- Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG (2019) (60)
- 9p21 locus analysis in high‐risk gastrointestinal stromal tumors characterized for c‐kit and platelet‐derived growth factor receptor α gene alterations (2005) (60)
- Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database (2016) (60)
- Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group (2019) (60)
- Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics (2013) (59)
- Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. (2017) (59)
- Postoperative Morbidity After Radical Resection of Primary Retroperitoneal Sarcoma tlantic RPS Working Group A Report From the Transa (2017) (58)
- Solitary fibrous tumors: loss of chimeric protein expression and genomic instability mark dedifferentiation (2015) (58)
- Head and neck soft tissue sarcomas: prognostic factors and outcome in a series of patients treated at a single institution. (2013) (58)
- Extra-abdominal desmoid fibromatosis: A review of management, current guidance and unanswered questions. (2016) (57)
- Impact of Concomitant Administration of Gastric Acid–Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials (2019) (57)
- Emerging therapies for adult soft tissue sarcoma (2014) (57)
- Anthracycline, Gemcitabine, and Pazopanib in Epithelioid Sarcoma: A Multi-institutional Case Series (2018) (57)
- Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis. (2015) (56)
- Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG)† (2018) (55)
- Gastrointestinal Stromal Tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 25, pg iii21, 2014) (2015) (54)
- Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour. (2014) (53)
- Resection of uninvolved adjacent organs can be part of surgery for retroperitoneal soft tissue sarcoma. (2009) (53)
- Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities (2021) (53)
- Preoperative radiation therapy for patients with T2–T3 carcinoma of the middle‐to‐lower rectum (1999) (51)
- SYT-SSX fusion genes and prognosis in synovial sarcoma (2001) (51)
- Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma. (2018) (50)
- Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution (2007) (48)
- Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. (2018) (47)
- Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution. (2011) (47)
- Corrections to "Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up". (2018) (47)
- Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST (2017) (47)
- High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial. (2018) (47)
- Preoperative nasopharyngeal swab testing and postoperative pulmonary complications in patients undergoing elective surgery during the SARS-CoV-2 pandemic (2020) (46)
- Long‐term morbidity after multivisceral resection for retroperitoneal sarcoma (2015) (45)
- Prognostic determinants in epithelioid sarcoma. (2011) (45)
- High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcoma (2014) (44)
- Surgical management of localized soft tissue tumors (2014) (44)
- Hemangiopericytoma in pediatric ages (2001) (43)
- Indications for surgery in advanced/metastatic GIST. (2016) (43)
- Surgery in Retroperitoneal Soft Tissue Sarcoma: A Call for a Consensus Between Europe and North America (2011) (43)
- Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2018) (43)
- New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration. (2019) (43)
- Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management (2009) (42)
- Gastrointestinal stromal tumors I: pathology, pathobiology, primary therapy, and surgical issues. (2009) (42)
- Lack of SYT-SSX Fusion Transcripts in Malignant Peripheral Nerve Sheath Tumors on RT-PCR Analysis of 34 Archival Cases (2002) (41)
- Tumor response to sunitinib malate observed in clear-cell sarcoma. (2010) (41)
- Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib (2013) (40)
- Erratum: Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Concensus Conference of 20-21 March 2004, under the auspices of ESMO (Annals of Oncology (2005) vol. 16 (566-578)) (2005) (40)
- Analysis of potential receptor tyrosine kinase targets in intimal and mural sarcomas (2007) (39)
- Adult-type soft tissue sarcomas in paediatric age: a nomogram-based prognostic comparison with adult sarcoma. (2007) (39)
- (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair. (2017) (39)
- Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups (2019) (39)
- HSPA8 as a novel fusion partner of NR4A3 in extraskeletal myxoid chondrosarcoma (2017) (38)
- Guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. (2015) (38)
- Vascular resection en-bloc with tumor removal and graft reconstruction is safe and effective in soft tissue sarcoma (STS) of the extremities and retroperitoneum. (2016) (38)
- Imatinib and everolimus in patients with progressing advanced chordoma: A phase 2 clinical study (2018) (37)
- Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study (2013) (36)
- Personalizing surgical margins in retroperitoneal sarcomas (2015) (36)
- Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center. (2014) (36)
- Isolated limb perfusion using tumour necrosis factor α and melphalan in patients with advanced aggressive fibromatosis (2014) (35)
- A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. (2012) (35)
- Activate and resist: L576P-KIT in GIST (2009) (35)
- Sunitinib malate in solitary fibrous tumor (SFT). (2012) (34)
- Personalizing surgical margins in retroperitoneal sarcomas: an update (2019) (34)
- Radiation-Induced Sarcoma of the Head and Neck: A Review of the Literature (2018) (33)
- Quality of Local Treatment or Biology of the Tumor: Which are the Trump Cards for Loco-regional Control of Retroperitoneal Sarcoma? (2013) (33)
- Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors (2019) (32)
- Hyperthermia as an adjunctive treatment for soft-tissue sarcoma (2009) (32)
- Prognostic relevance of ALT-associated markers in liposarcoma: a comparative analysis (2010) (32)
- The Combination of Surgery and Imatinib in GIST: A Reality for Localized Tumors at High Risk, an Open Issue for Metastatic Ones (2012) (32)
- Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG. (2016) (31)
- Soft tissue sarcomas of childhood and adolescence: the prognostic role of tumor size in relation to patient body size. (2009) (30)
- Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG) (2018) (30)
- Phase II study on lapatinib in advanced EGFR-positive chordoma. (2013) (30)
- Perioperative Management of Extremity Soft Tissue Sarcomas. (2018) (29)
- Treatment challenges in and outside a network setting: Soft tissue sarcomas. (2017) (29)
- Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib (2012) (28)
- Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma (2019) (28)
- Prognostic Factors and Outcome of Spermatic Cord Sarcoma (2014) (28)
- The role of high‐dose imatinib in the management of patients with gastrointestinal stromal tumor (2010) (28)
- The need of COVID19 free hospitals to maintain cancer care (2020) (28)
- Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment. (2017) (28)
- Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib. (2020) (27)
- Desmoid tumors: To treat or not to treat, That is the question (2020) (27)
- Risk stratification models and mutational analysis: keys to optimising adjuvant therapy in patients with gastrointestinal stromal tumour. (2013) (27)
- Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years (2020) (27)
- Treatment of Desmoid Tumors in 2019. (2019) (27)
- European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy. (2018) (26)
- MRP1 Overexpression Determines Poor Prognosis in Prospectively Treated Patients with Localized High-Risk Soft Tissue Sarcoma of Limbs and Trunk Wall: An ISG/GEIS Study (2013) (26)
- Novel Models of Myxoid Liposarcoma Xenografts Mimicking the Biological and Pharmacologic Features of Human Tumors (2010) (26)
- Evidence of Neural Differentiation in a Case of Post-therapy Primitive Neuroectodermal Tumor/Ewing Sarcoma of Bone (2003) (26)
- AKT1 and BRAF mutations in pediatric aggressive fibromatosis (2016) (25)
- Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial. (2020) (25)
- Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study. (2019) (25)
- Adequate Local Control in High-Risk Soft Tissue Sarcoma of the Extremity Treated with Surgery Alone at a Reference Centre: Should Radiotherapy Still be a Standard? (2018) (24)
- The management of surgical patients during the coronavirus disease 2019 (COVID-19) pandemic (2020) (24)
- Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study (2017) (24)
- Feasibility of Peritonectomy Associated with Intraperitoneal Hyperthermic Perfusion in Patients with Pseudomyxoma Peritonei (2002) (23)
- Extraskeletal Myxoid Chondrosarcoma with Molecularly Confirmed Diagnosis: A Multicenter Retrospective Study Within the Italian Sarcoma Group (2020) (23)
- Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial–Mesenchymal Transition–like Process and 22q Loss (2016) (23)
- Adjuvant Therapy of Gastrointestinal Stromal Tumors (GIST) (2012) (23)
- Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour. (2017) (23)
- Oncogenic and ligand‐dependent activation of KIT/PDGFRA in surgical samples of imatinib‐treated gastrointestinal stromal tumours (GISTs) (2009) (23)
- Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors? (2008) (23)
- Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet (2020) (23)
- Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials. (2018) (22)
- Systemic treatments in MDM2 positive intimal sarcoma: A multicentre experience with anthracycline, gemcitabine, and pazopanib within the World Sarcoma Network (2019) (22)
- Neoadjuvant chemotherapy in high‐risk soft tissue sarcomas: A Sarculator‐based risk stratification analysis of the ISG‐STS 1001 randomized trial (2021) (22)
- Receptor tyrosine kinase pathway analysis sheds light on similarities between clear‐cell sarcoma and metastatic melanoma (2012) (22)
- sarcomaFull-dose neoadjuvant anthracycline + ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: Interim analysis of a prospective randomized trial (2016) (22)
- Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 (2017) (21)
- Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG) (2021) (21)
- NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas (2019) (21)
- The sacral chordoma margin. (2020) (21)
- In vitro and in silico studies of MDM2/MDMX isoforms predict Nutlin-3A sensitivity in well/de-differentiated liposarcomas (2013) (21)
- Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (2020) (21)
- Telomere maintenance mechanisms in malignant peripheral nerve sheath tumors: expression and prognostic relevance. (2012) (20)
- Imatinib response in two GIST patients carrying two hitherto functionally uncharacterized PDGFRA mutations: An imaging, biochemical and molecular modeling study (2011) (20)
- β‐Catenin in desmoid‐type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression (2017) (20)
- Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management (2020) (20)
- Banked venous homograft replacement of the inferior vena cava for primary leiomyosarcoma. (2008) (19)
- Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy (2014) (19)
- The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only (2019) (19)
- Surgery in soft tissue sarcoma: more conservative in extremities, more extended in the retroperitoneum (2012) (19)
- Atypical pleomorphic epithelioid angiomyolipoma localized to the pelvis: a case report and review of the literature (2004) (19)
- Activity of anthracycline- and ifosfamide-based chemotherapy in a series of patients affected by advanced myxofibrosarcoma (2017) (19)
- Treatment Outcomes and Sensitivity to Hormone Therapy of Aggressive Angiomyxoma: A Multicenter, International, Retrospective Study. (2019) (18)
- Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma. (2018) (18)
- Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma (2017) (18)
- Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft (2019) (17)
- Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention (2016) (17)
- Imatinib mesylate in advanced chordoma: A multicenter phase II study (2007) (17)
- The Diagnosis and Management of Retroperitoneal Sarcoma. (2018) (17)
- JNCCN NCCN Task Force Report : Optimal Management of Patients with Gastrointestinal Stromal Tumor ( GIST ) — Update of the NCCN Clinical Practice Guidelines (2007) (17)
- Identification of a gene expression driven progression pathway in myxoid liposarcoma (2014) (17)
- p15 INK4b , p14 ARF , and p16 INK4a Inactivation in Sporadic and Neurofibromatosis Type 1-related Malignant Peripheral Nerve Sheath Tumors 1 (2003) (17)
- Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG (2020) (17)
- The activity of chemotherapy in inflammatory myofibroblastic tumour (IMT): a multicentre, European retrospective case series analysis. (2020) (17)
- Staging, nomograms and other predictive tools in retroperitoneal soft tissue sarcoma. (2018) (17)
- Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma. (2012) (17)
- Adding cisplatin (CDDP) to imatinib (IM) re-establishes tumor response following secondary resistance to IM in advanced chordoma (2007) (17)
- Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma. (2019) (17)
- Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of Surgical Oncology (2020) (16)
- Chordoma (2007) (16)
- Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach (2018) (16)
- Novel intra‐genic large deletions of CTNNB1 gene identified in WT desmoid‐type fibromatosis (2018) (16)
- Surgical management of retroperitoneal sarcoma and opportunities for global collaboration. (2018) (16)
- Surgical management of oncologic patient during and after the COVID-19 outbreak: practical recommendations from the Italian society of Surgical Oncology (2020) (16)
- Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study. (2021) (16)
- Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy. (2016) (16)
- Axial skeletal osteosarcoma: a 25-year monoinstitutional experience in children and adolescents (2014) (16)
- Adjacent, Adherent, Invaded: A Spectrum of Biologic Aggressiveness Rather Than a Rationale for Selecting Organ Resection in Surgery of Primary Retroperitoneal Sarcomas (2017) (15)
- Malnutrition and Perioperative Nutritional Support in Retroperitoneal Sarcoma Patients: Results from a Prospective Study (2019) (15)
- Optimal Approach to Sporadic Desmoid Tumors: From Radical Surgery to Observation. Time for a Consensus? (2012) (15)
- Desmoid-type fibromatosis: what works best? (2009) (15)
- Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult (2013) (15)
- Historical perspectives and future directions in the surgical management of retroperitoneal sarcoma (2018) (15)
- Treatment of localized sarcomas. (2013) (14)
- Angiosarcoma of the Breast and Vascular Endothelial Growth Factor Receptor (2010) (14)
- CT, [18F]FDG-PET/CT and clinical findings before and during early Covid-19 onset in a patient affected by vascular tumour (2020) (14)
- Treatment of soft tissue sarcoma: a focus on earlier stages. (2017) (14)
- Local Ablative Therapies to Metastatic Soft Tissue Sarcoma. (2016) (14)
- Addition of Antiestrogen Treatment in Patients with Malignant PEComa Progressing to mTOR Inhibitors (2020) (14)
- The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): “Red wine or white”? (2016) (14)
- Pharmacological therapies for Liposarcoma (2017) (13)
- Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors. (2013) (13)
- Sensitivity of myxoid-round cell liposarcoma (MRCL) to trabectedin (T) may be related to a direct effect on the fusion transcript (2007) (13)
- Renal angiomyolipomas: At least two diseases. A series of patients treated at two European institutions. (2017) (13)
- ILP and RT: The Study That Will Never Be (2011) (13)
- 13LBA Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study (2015) (13)
- Surgery of residual disease following imatinib mesylate in advanced gastrointestinal stromal tumors (GIST) (2005) (13)
- High CD133 expression levels in gastrointestinal stromal tumors (2011) (13)
- The role of hyperthermic intraperitoneal chemotherapy (HIPEC) and isolated perfusion (ILP) interventions in sarcoma (2015) (13)
- Working to improve the management of sarcoma patients across Europe: a policy checklist (2018) (13)
- ALT‐associated promyelocytic leukaemia body (APB) detection as a reproducible tool to assess alternative lengthening of telomere stability in liposarcomas (2007) (13)
- Response to sirolimus in combination to tirosine kinase inhibitors (TKI) in three cases of PDGFRA-D842V metastatic gastrointestinal stromal tumor (GIST). (2009) (13)
- The natural history of epithelioid sarcoma. A retrospective multicentre case-series within the Italian Sarcoma Group. (2020) (13)
- Combined modalities approach for localized adult extremity soft-tissue sarcoma (2007) (12)
- Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin (2021) (12)
- Accreditation for centers of sarcoma surgery (2017) (12)
- Soft-tissue sarcomas of the extremities in patients of pediatric age (2007) (12)
- Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia). (2020) (12)
- Localised thoracic sarcomas: outcome improvement over time at a single institution. (2013) (12)
- 1486PAn epidemiological insight into epithelioid sarcoma (ES): The open issue of distal-type (DES) versus proximal-type (PES) (2017) (12)
- Second Primary Malignancies in Patients with Well-differentiated/Dedifferentiated Liposarcoma (2018) (11)
- A call to action: Why sarcoma surgery needs to be centralized (2018) (11)
- Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma: EORTC-62092 Trial (STRASS) Versus Off-trial (STREXIT) Results. (2022) (11)
- Uterine Sarcoma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion: a Feasiblity Study (2004) (11)
- Sunitinib malate (SM) in alveolar soft part sarcoma (ASPS). (2010) (11)
- Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies. (2014) (11)
- Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy (2019) (11)
- A phase II clinical trial of neoadjuvant trabectedin in patients with nonmetastatic advanced myxoid/round cell liposarcoma (MRCL). (2009) (11)
- Morcellator's Port-site Metastasis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential After Minimally Invasive Myomectomy. (2016) (11)
- Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management (2012) (11)
- Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue (2017) (11)
- The Value of Neoadjuvant Chemotherapy in Localized High-Risk Soft-Tissue Sarcoma of the Extremities and Trunk (2018) (10)
- Unplanned Excision of Extremity and Trunk Wall Soft Tissue Sarcoma: To Re-resect or Not to Re-resect? (2021) (10)
- Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2021) (10)
- Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis (2020) (10)
- Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy (2011) (10)
- Update on management of GIST and postsurgical use of imatinib (2010) (10)
- Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis (2018) (10)
- Individualizing Follow-Up Strategies in High-Grade Soft Tissue Sarcoma with Flexible Parametric Competing Risk Regression Models (2019) (10)
- A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients. (2012) (10)
- Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies (2022) (9)
- Improved Biopsy Accuracy in Retroperitoneal Dedifferentiated Liposarcoma (2020) (9)
- Response to imatinib mesylate (IM) in fibrosarcoma (FS) arising in dermatofibrosarcoma protuberans (DFSP) (2008) (9)
- Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin (2019) (9)
- Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study (2021) (9)
- Activity of toremifene in sporadic desmoid-type fibromatosis. (2011) (9)
- Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation (2021) (9)
- Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms. (2021) (9)
- Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas (2019) (9)
- Response to sunitinib malate (SM) in alveolar soft part sarcoma (ASPS) (2008) (9)
- A Prospective Observational Study of Multivisceral Resection for Retroperitoneal Sarcoma: Clinical and Patient-Reported Outcomes 1 Year After Surgery (2020) (9)
- Predictors for doxorubicin-induced hematological toxicity and its association with outcome in advanced soft tissue sarcoma patients; a retrospective analysis of the EORTC-soft tissue and bone sarcoma group database (2018) (8)
- A proposal of an updated classification for pelvic relapses of rectal cancer to guide surgical decision‐making (2020) (8)
- Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue. (2017) (8)
- Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution (2020) (8)
- Quality of surgery and surgical reporting for patients with primary gastrointestinal stromal tumours participating in the EORTC STBSG 62024 adjuvant imatinib study. (2019) (8)
- Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma (2020) (8)
- Major vascular resection in retroperitoneal sarcoma surgery. (2021) (8)
- [Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei]. (2003) (8)
- Individualizing the use/non‐use of radiation therapy (RT) in soft tissue sarcoma (STS): When abstention is better than care (2015) (8)
- Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (2021) (8)
- Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments (2019) (8)
- Thoracopleuropneumonectomy with Riblike Reconstruction for Recurrent Thoracic Sarcomas (2014) (8)
- Neoadjuvant treatment: a novel standard? (2017) (8)
- Critical impact of radiotherapy protocol compliance and quality in the treatment of retroperitoneal sarcomas: Results from the EORTC 62092‐22092 STRASS trial (2021) (8)
- Intraperitoneal Invasion of Retroperitoneal Sarcomas: A Risk Factor for Dismal Prognosis (2019) (8)
- Neoadjuvant (re)chemoradiation for locally recurrent rectal cancer: Impact of anatomical site of pelvic recurrence on long-term results. (2020) (8)
- Extended surgery for retroperitoneal sarcoma: the key to maximizing the potential for cure and survival. Pro. (2013) (8)
- Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: Final results of a randomized clinical trial from the Italian Sarcoma Group, the Spanish Sarcoma Group (GEIS), the French Sarcoma Group (FSG), and the Polish Sarcoma Group (PSG). (2019) (7)
- Evaluation of the antitumor activity of sunitinib malate (SM) in solitary fibrous tumor (SFT). (2016) (7)
- Morbidity of left pancreatectomy when associated with multivisceral resection for abdominal mesenchymal neoplasms. (2011) (7)
- Surrogate endpoints in advanced sarcoma trials: a meta-analysis (2018) (7)
- Rechallenge with trabectedin in patients with responding myxoid liposarcoma. (2016) (7)
- Completion surgery of residual disease after primary inadequate surgery of retroperitoneal sarcomas can salvage a selected subgroup of patients—A propensity score analysis (2018) (7)
- An Update on Non-extremity Soft Tissue Sarcomas. (2017) (7)
- High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma (2017) (7)
- A prospective observational study of Active surveillance in primary desmoid fibromatosis. (2022) (7)
- Staging systems and nomograms in soft tissue sarcoma: outcome prediction by categorization or personalization? (2019) (7)
- Doxorubicin plus dacarbazine (DoDa), doxorubicin plus ifosfamide (DI) or doxorubicin alone (Do) as first line treatment for advanced leiomyosarcoma (LMS): A retrospective study from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG). (2018) (7)
- Diagnosis strategy of adipocytic soft-tissue tumors in adults: a consensus from European experts. (2021) (7)
- Minimally Invasive Surgery for Retroperitoneal Sarcoma: Just Because We Can Does Not Mean We Should (2018) (6)
- Sarcoma nomograms: a light over the darkness (2017) (6)
- The safety and efficacy of trabectedin for the treatment of liposarcoma or leiomyosarcoma (2016) (6)
- Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database study. (2018) (6)
- Cytoreductive Surgery in Advanced GIST: Timing is Everything (2013) (6)
- Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial (2018) (6)
- Global Forum of Cancer Surgeons: Position Statement to Promote Cancer Surgery Globally (2020) (6)
- Clear cell sarcoma (CCR): Clinical behavior and response to chemotherapy. (2010) (6)
- 2018 ESMO Sarcoma and GIST Symposium: ‘take-home messages’ in soft tissue sarcoma (2018) (6)
- Clinical prognostic factors in advanced epithelioid haemangioendothelioma: a retrospective case series analysis within the Italian Rare Cancers Network (2021) (6)
- The Landmark Series: Multimodality Treatment of Extremity Sarcoma (2020) (6)
- Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase II trial in localized myxoid liposarcoma—A collaborative Spanish (GEIS), Italian (ISG) and French (FSG) group study. (2020) (6)
- CT imaging improves histopathological grading of retroperitoneal leiomyosarcomas. (2020) (6)
- Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program (2021) (5)
- Gastrointestinal stromal tumor of the rectum and rectovaginal space: A retrospective review (2008) (5)
- Preoperative chemoradiation therapy for localized retroperitoneal soft tissue sarcoma (RSTS): A phase II study from the Italian Sarcoma Group. (2011) (5)
- Leiomyosarcoma and sarcoma with myogenic differentiation (2012) (5)
- Uterine sarcoma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion: a feasiblity study. (2004) (5)
- Oncological outcomes after major vascular resections for primary retroperitoneal liposarcoma. (2021) (5)
- Liver resection for sarcoma metastases: A systematic review and experience from two European centres. (2020) (5)
- Surgery in soft tissue sarcoma: the thin line between a surgical or more conservative approach. (2021) (5)
- Sirolimus in advanced hemangioendothelioma. (2013) (4)
- Fluorescence in situ hybridization analysis and immunophenotyping of c-Kit/PDGFRA and Bcl-2 expression in gastrointestinal stromal tumors. (2010) (4)
- Abdominosacral resection for locally recurring rectal cancer (2016) (4)
- Activity of chemotherapy in inflammatory myofibroblastic tumor (IMT): A retrospective analysis within the Italian Rare Tumours Network (RTR). (2019) (4)
- Consistent Margin-Status Reporting in Soft Tissue Sarcoma Is Essential to Establish Risk-Adapted Strategies Integrating Biology and Histotype in Perioperative Treatments. (2018) (4)
- Cancer registries and randomised clinical trials in rare tumours: At the two extremes of daily clinical practice. (2016) (4)
- A phase II/III trial of hafnium oxide nanoparticles activated by radiotherapy in the treatment of locally advance soft tissue sarcoma of the extremity and trunk wall. (2018) (4)
- Prognostic value of microscopic evaluation of organ infiltration and visceral resection margins (VRM) in patients with retroperitoneal sarcomas (RPS). (2017) (4)
- Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall: Outcome Improvement Over Time at a Single Institution (2022) (4)
- The evolving role of patient advocates in rare cancers: opportunities and challenges (2018) (4)
- Highlights in soft tissue sarcomas and gastrointestinal stromal tumours (GIST) trials reported at ASCO 2017 Annual Meeting (2017) (4)
- Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments. (2022) (4)
- Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (2022) (4)
- Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma (2018) (4)
- Global Forum of Cancer Surgeons: Cancer Surgery During the COVID-19 Pandemic: Impact and Lessons Learned (2022) (4)
- Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor (2022) (4)
- Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID‐19 Pandemic (2020) (4)
- Sarcomas of soft tissues and bone (2016) (4)
- Prognostic stratification using the nomogram sarculator and its impact on study results in a randomized controlled trial (RCT) for localized soft tissue sarcomas (STS): A secondary analysis of the EORTC-STBSG 62931. (2018) (4)
- Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients (2022) (4)
- Pexidartinib for the treatment of adult symptomatic patients with tenosynovial giant cell tumors (2020) (4)
- When does a new sarcoma exist? (2020) (4)
- Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID‐19 pandemic: A guide for surgical oncologists (2020) (4)
- Are We Allowed to Limit Surgical Aggressiveness With Small Rectal Gastrointestinal Stromal Tumors? (2017) (4)
- Local Ablative Therapies to Metastatic Soft Tissue Sarcoma. (2016) (3)
- The prognostic value of CINSARC in a randomised trial comparing histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001). (2020) (3)
- Management of serious complications in intra‐abdominal desmoid‐type fibromatosis (2021) (3)
- The sarculator stratified prognosis of patients with high-risk soft tissue sarcomas (STS) of extremities and trunk wall treated with perioperative chemotherapy in a randomised controlled trial (RCT). (2017) (3)
- Sunitinib malate in advanced alveolar soft part sarcoma (ASPS): A final update after the closure of the named use program. (2015) (3)
- Dedifferentiation within well‐differentiated liposarcoma of the extremity or trunk: Implications for clinical management (2021) (3)
- Trabectedin and radiotherapy in soft-tissue sarcoma (TRASTS) study: An international, prospective, phase I/II trial—A collaborative Spanish (GEIS), Italian (ISG), and French (FSG) groups study. (2017) (3)
- Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohort. (2022) (3)
- Effect of adding sirolimus (s) to imatinib (im) on tumor response following secondary resistance to im in advanced chordoma (2008) (3)
- Head and neck adult-type soft tissues sarcomas: survival analysis and comparison between the last two editions of the TNM staging system (2020) (3)
- Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid‐type fibromatosis (2021) (3)
- Retroperitoneal sarcomas: Big tumors that involve more than just “Getting it Out” (2017) (3)
- Primary mesenteric sarcomas: Collaborative experience from the Trans‐Atlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2020) (3)
- Residual Adrenal Function After Multivisceral Resection With Adrenalectomy in Adult Patients. (2022) (3)
- Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma (2022) (3)
- Neurofibromin C terminus-specific antibody (clone NFC) is a valuable tool for the identification of NF1-inactivated GISTs (2018) (3)
- 3401 Absence of progression, not extent of remission defines prognosis in soft tissue sarcoma - an analysis of the EORTC 62012 study (2015) (2)
- Surgery in patients with metastatic or recurrent gastrointestinal stromal tumor (GIST) upon best response or limited progression following imatinib therapy (2008) (2)
- b-Catenin in desmoid-type fibromatosis : deep insights into the role of T 41 A and S 45 F mutations on protein structure and gene expression (2017) (2)
- 1496PEORTC experience with advanced/metastatic epithelioid sarcoma patients treated in prospective trials: Clinical profile and response to systemic therapy (2017) (2)
- Predicting survival in primary resected retroperitoneal soft tissue sarcoma: A specific nomogram built on three major sarcoma center data sets. (2012) (2)
- Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study. (2021) (2)
- The sarculator predicted risk of distant metastasis and overall survival in patients with high-risk soft tissue sarcoma treated with perioperative chemotherapy in a randomised controlled trial (2018) (2)
- Erratum to: The Combination of Surgery and Imatinib in GIST: A Reality for Localized Tumors at High Risk, an Open Issue for Metastatic Ones (2012) (2)
- Correction: Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas (2020) (2)
- Surgical resection as an adjuvant to tyrosine kinase inhibitors in metastatic GIST: Association or causation?/Are we any closer to an answer? (2018) (2)
- A sommelier to guide wine selection and a specialist to manage the sarcoma patient: Barriers to referral and definition of a sarcoma specialist (2020) (2)
- Synovial sarcomas of the upper aero-digestive tract: is there a role for conservative surgery? (2018) (2)
- Analysis of the quality of reporting surgical procedures in patients undergoing resection for primary gastrointestinal stromal tumors: A reporting tool derived from the EORTC–STBSG 62024 trial. (2012) (2)
- Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma. (2022) (2)
- Global Forum of Cancer Surgeons: Support for the Brazilian Society of Surgical Oncology Journey towards Implementation of Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy in Brazil (2021) (2)
- Angiosarcoma of the breast and VEGF-R expression (2008) (2)
- Current Treatment of Retroperitoneal Sarcomas (2018) (2)
- Neoadjuvant denosumab treatment of locally advanced giant cell tumor of bone (GCTB). (2017) (2)
- Towards the standard use of (neo)adjuvant chemotherapy in selected localised soft tissue sarcoma at high risk of relapse: are we finally getting there? (2018) (2)
- Surgery for recurrence in retroperitoneal leiomyosarcoma: Is it all about selection? (2017) (2)
- Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial (2021) (2)
- Long-term benefit from trabectedin (T) in myxoid liposarcoma (MLS) patients (2008) (2)
- WHO Pathology: Highlights of the 2020 Sarcoma Update. (2022) (2)
- Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study. (2022) (2)
- Treatment modalities and long-term outcomes of hepatic hemangioendothelioma in the United States. (2022) (2)
- 1502PEvolution in neutrophil-to-lymphocyte ratio (NLR) among advanced soft tissue sarcoma (STS) patients treated with pazopanib within EORTC 62043/62072 trials (2017) (2)
- Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional TARPSWG study. (2020) (2)
- How to treat liposarcomas located in retroperitoneum. (2022) (2)
- Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas—Looking Forward (2022) (2)
- Delayed Gastric Emptying After Multivisceral Resection for Retroperitoneal Sarcoma (2022) (2)
- Multi-institutional European phase I/II trial of trabectedin plus radiotherapy in metastaticsoft tissue sarcoma (STS) patients. A Collaborative Spanish (GEIS), Italian (ISG) and French (FSG) Sarcoma Groups study. (2018) (2)
- Sacro-coccygeal chordoma: Diagnosis and treatment review (2004) (2)
- Multicenter retrospective analysis of 31 patients with aggressive angiomyxoma. (2014) (2)
- The Italian Society of Surgical Oncology (SICO) survey on the minimum requirements of rare cancers referral centers (2016) (2)
- Immune contexture in high-risk soft tissue sarcomas (STS): A planned analysis of the ISG-STS-1001 randomized trial. (2021) (1)
- Tumor response and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS). (2011) (1)
- Histology and outcome in localized high-risk soft tissue sarcomas (STS) treated with preoperative chemotherapy (CHT) with or without radiation therapy (RT) within a phase III trial from the Italian Sarcoma Group (ISG) and the Spanish Sarcoma Group (GEIS). (2011) (1)
- Sunitinib (SM) in advanced extraskeletal myxoid chondrosarcoma (EMC): Updated analysis in 11 patients (pts). (2016) (1)
- ASO Author Reflections: Evolving Concepts for Radiation Therapy in Extremity and Trunk Soft Tissue Sarcoma (2018) (1)
- Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in angiosarcoma and leiomyosarcoma. (2016) (1)
- Erratum to: Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy? (2011) (1)
- High-risk soft tissue sarcoma of extremity and trunk wall: A retrospective comparison of local control in patients treated with or without radiation therapy at a single reference center. (2015) (1)
- The Impact of Chemotherapy on Survival of Patients with Extremity and Trunk Wall Soft Tissue Sarcoma: Revisiting the Results of the EORTC-STBSG 62931 Randomised Trial Using Sarculator, a Validated Nomogram-Based Risk Assessment Tool (2018) (1)
- Management of complicated tumor response to tyrosine‐kinase inhibitors in gastrointestinal stromal tumors (2019) (1)
- Primary malignancy of the inferior vena cava, a review of surgical treatments and outcomes. (2022) (1)
- Extraskeletal myxoid chondrosarcoma: A retrospective analysis of 69 patients with localized disease and molecularly confirmed diagnosis. (2014) (1)
- Peritoneal mesothelioma treated by cytoreductive surgery and intra peritoneal hyperthermic perfusion: Clinical and translational study. (2004) (1)
- First‐line chemotherapy in advanced intra‐abdominal well‐differentiated/dedifferentiated liposarcoma: An EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis (2022) (1)
- Solitary fibrous tumor: A retrospective analysis on 65 patients from a reference center. (2016) (1)
- Botulinum toxin type A affects the transcriptome of cell cultures derived from muscle biopsies of controls and spastic patients. (2018) (1)
- The Prognostic Role of b -Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only A Meta-analysis of individual Patient Data M ETA -A NALYSIS (1)
- Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas. (2023) (1)
- Preoperative chemoradiation therapy for localized retroperitoneal sarcoma (RPS): Final results of a phase II study from the Italian Sarcoma Group. (2013) (1)
- Tyrosine kinase inhibitor therapies for gastrointestinal stromal tumours (2018) (1)
- Long-Term Results of Thoraco-Pleuro-Pneumonectomy (TPP) for Recurrent Thoracic Sarcomas (2017) (1)
- Retroperitoneal Sarcoma Involving the Inferior Vena Cava (2017) (1)
- Coexistence of gastrointestinal stromal tumor (GIST) with desmoid tumor (DT): Case series of 22 patients. (2010) (1)
- Identification of an actionable mutation of KIT in extraskeletal myxoid chondrosarcoma (EMC). (2018) (1)
- Relationship of CUL4A gene underexpression and prognosis in localized high-risk soft tissue sarcoma (STS) patients of limbs or trunk wall. (2012) (1)
- History of Surgery in Retroperitoneal Sarcomas (2019) (1)
- ASO Author Reflections: Moving the Needle in Extremity and Trunk Soft Tissue Sarcoma (2020) (1)
- The evolution of adjuvant/neoadjuvant trials for resectable localized sarcoma (2021) (1)
- Doxorubicin (D), gemcitabine (G), ifosfamide (I) and the EZH2 inhibitor EPZ-011989 in epithelioid sarcoma (ES): A comparison of different regimens in a patient-derived xenograft (PDX) model. (2018) (1)
- Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group retrospective analysis (2016) (1)
- Postnephrectomy outcomes following en bloc resection of primary retroperitoneal sarcoma: multicentre study. (2021) (1)
- Quality of Sarcoma Care: Longitudinal Real-Time Assessment and Evidence Analytics of Quality Indicators (2022) (1)
- Hafnium Oxide Nanoparticles Activated By Radiation Therapy for the Treatment of Solid Tumors (2018) (1)
- Time to secondary resistance (TTSR) after rechallenge with trabectedin (T) in myxoid round cell liposarcoma (MRCLPS) patients. (2015) (1)
- Long-term results with combined treatment in adult localized extraskeletal Ewing's sarcoma (ES): A retrospective analysis of 51 patients (pts) from a single referral center. (2016) (1)
- Characterization of tumor microenvironment in extraskeletal myxoid chondrosarcoma (EMC). (2018) (1)
- CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study (2022) (1)
- Tumor response assessment by Choi criteria in localized high-risk soft tissue sarcoma (STS) treated with chemotherapy (CT): Update at 10-year follow-up of an exploratory analysis on a phase III trial. (2016) (1)
- Reversion of resistance to mTOR inhibitors with the addition of exemestane in patients with malignant PEComa (2019) (1)
- Impact of pathological stratification of advanced well differentiated/dedifferentiated (WD/DD) liposarcoma (LPS) on the response to trabectedin (T). (2018) (1)
- Regorafenib (R) in advanced solitary fibrous tumor (SFT): Results from an exploratory phase II clinical study. (2021) (1)
- Telomere as a Therapeutic Target in Dedifferentiated Liposarcoma (2022) (1)
- Cancer networks as a response to COVID pandemic: A framework from the Italian Society of Surgical Oncology (2021) (1)
- ASO Author Reflections: Selecting Patients for Recurrent Retroperitoneal Sarcoma Surgery: The Challenging Trade-Off Between Oncologic Outcome and Morbidity (2021) (1)
- Metastatic dermatofibrosarcoma protuberans (DFSP) and fibrosarcomatous DFSP (FS-DFSP): Sensitivity to imatinib (IM) and gene expression profile. (2015) (1)
- Locally recurrent extraskeletal myxoid chondrosarcoma of the shoulder: a case of complete neoadjuvant radiotherapy response (2020) (1)
- Virtual Biobanking for Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Initiative (2020) (1)
- Datasets for reporting of soft‐tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) (2023) (1)
- Effectiveness and Safety of Trabectedin and Radiotherapy for Patients With Myxoid Liposarcoma: A Nonrandomized Clinical Trial. (2023) (1)
- Efficacy of methotrexate + vinblastine in intra-abdominal desmoid (mesenteric aggressive fibromatosis): Retrospective analysis of 29 patients from a single institution (2008) (1)
- Long-term survivors with desmoplastic small round cell tumor (DSRCT): Results from a retrospective single-institution case series analysis. (2023) (1)
- Corrigendum to "Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia)" [Eur J Canc. vol. 139 November (2020) Pages 149-168]. (2020) (1)
- Active surveillance in primary desmoid tumor (DT): A prospective observational study. (2021) (1)
- Soft tissue and visceral sarcomas (1)
- First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults (2016) (1)
- LBA55Time to definitive failure to the first tyrosine kinase inhibitor in localized gastrointestinal stromal tumors (GIST) treated with imatinib as an adjuvant: Final results of the EORTC STBSG, AGITG, UNICANCER, FSG, ISG, and GEIS randomized trial (2017) (1)
- Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy An (2018) (0)
- 9420 POSTER Sirolimus in Epithelioid Hemangioendothelioma (2011) (0)
- 1483PDImatinib in combination with everolimus in patients with progressive advanced chordoma: results form an Italian phase 2 clinical trial (2017) (0)
- Activity of chemotherapy in a series of patients with locally advanced or metastatic pleomorphic rhabdomyosarcoma: A retrospective analysis. (2014) (0)
- Radiologic and pathologic response to trabectedin (T) in myxoid liposarcomas (MLS): An exploratory study in 7 patients (2008) (0)
- Act.in.Sarc: An International Randomized Phase III Trial Evaluating Efficacy and Safety of First-in-Class NBTXR3 Hafnium Oxide Nanoparticles Activated By Preoperative Radiotherapy in Locally Advanced Soft Tissue Sarcoma (2018) (0)
- Retroperitoneal Liposarcoma: An Aggressive Strategy to Maximize Disease Control. (2017) (0)
- Management of advanced and/or metastatic GIST (2007) (0)
- Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer. (2023) (0)
- Refining the approach to patients with primary soft tissue sarcoma of the extremities and trunk wall (ESTSTS): Outcome improvement over 30 years at a single institution. (2021) (0)
- ASO Author Reflections: Reexcision after Macroscopically Complete Unplanned Excision in Extremity and Trunk Wall Soft Tissue Sarcoma: Is Less More? (2021) (0)
- 1 Dissecting β-catenin associated inflammation in patients with desmoid fibromatosis to identify prognostic biomarkers (2021) (0)
- Natural history and outcome in a large series of primary dermatofibrosarcoma protuberans (DFSP) treated at a reference institution. (2015) (0)
- Prognostic role of MRP1 in localized high-risk soft tissue sarcoma (STS): Translational research associated to randomized phase III trial (ISG-STS 1001). (2020) (0)
- Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2022) (0)
- Clinical Cancer esearch linical Therapy el Models of Myxoid Liposarcoma Xenografts Mimicking Biological and Pharmacologic Features of R an Tumors (2010) (0)
- Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin (2020) (0)
- Abstract 1183: PPARgamma agonist promotes adipocytic differentiation and potentiates the activity of trabectedin in myxoid liposarcoma (2016) (0)
- Perioperative morbidity in metastatic gastrointestinal stromal tumors (GIST) undergoing surgery of residual disease following imatinib (IM) (2007) (0)
- This is a repository copy of Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation (2018) (0)
- Activity/modeling of imatinib against gatrointestinal stromal tumors carrying PDGFRA mutations in exons 18 and 12 (2008) (0)
- Angiosarcoma of the Breast and Vascular Endothelial Growth Factor Receptor (2010) (0)
- 100 Angiosarcoma of the breast and vascular endothelial growth factor receptor (2010) (0)
- Tailored Beta-catenin mutational approach in extra-abdominal sporadic desmoid tumor patients without therapeutic intervention (2016) (0)
- Identification of novel intra-genic deletions of CTNNB1 gene in WT desmoid-type fibromatosis. (2018) (0)
- Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2022) (0)
- ASO Visual Abstract: Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas. (2023) (0)
- ASO Author Reflections: Management of Locally Recurrent Retroperitoneal Sarcoma: The Balance is Tipped Towards Biology (2022) (0)
- Sarcomas of soft tissues and bone and gastrointestinal stromal tumour (2016) (0)
- Staging Systems and Nomograms for Soft Tissue Sarcoma (2023) (0)
- Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG) (2022) (0)
- Principles of Local Therapy of Soft Tissue Neoplasms (2019) (0)
- 1493PThe sarcoma policy checklist: Focusing policy efforts on sarcoma (2017) (0)
- Correction: Radiotherapy in Retroperitoneal Liposarcoma: Are We Looking for an Answer in the Wrong Place? (2022) (0)
- Chordoma of the mobile spine: A retrospective analysis on 146 patients from two reference centers. (2009) (0)
- 413 INVITED Desmoid Type Fibromatosis: How Much Surgery and When? (2011) (0)
- This is a repository copy of Impact of concomitant administration of gastric acid-suppressive agents and pazopanib on outcomes in soft-tissue sarcoma patients (2020) (0)
- High-dose photon-beam radiation therapy in chordoma: A single-institution retrospective analysis. (2010) (0)
- Radiomic features for patients with primary soft tissue sarcomas: A prognostic study. (2020) (0)
- Surgery of residual disease of myxoid liposarcoma (MLS) patients responding to trabectedin. (2010) (0)
- Overall survival in abdominal wall sarcoma treated with curative intent surgery: A retrospective study from two European referral centres (2022) (0)
- Myoepithelial tumours of soft tissues and extraskeletal myxoid chondrosarcomas feature a distinct transcriptional pattern (2019) (0)
- Primary epithelioid angiosarcoma. (2014) (0)
- Retroperitoneal soft tissue sarcoma (RPS): Recent outcome improvement and refinement of treatment strategies at a single institution. (2019) (0)
- Preoperative Neutrophil-To-Lymphocyte Ratio And A New Inflammatory Biomarkers Prognostic Index For Primary Retroperitoneal Sarcomas. (2022) (0)
- ASO Author Reflections: A Breach in the Border—Retroperitoneal Sarcoma with an Intraperitoneal Component (2019) (0)
- Distal Pancreatectomy for Primary Retroperitoneal Sarcoma—Clinical Implications and Future Directions (2021) (0)
- The Ever-Evolving Landscape of Sarcomas: A 2022 Update on This Complex Family of Diseases. (2022) (0)
- Predicting the Risk of Recurrence in Retroperitoneal Sarcoma (2019) (0)
- Gastrointestinal Stromal Tumors (GISTs) (2021) (0)
- Association of hematological toxicity (tox) and outcome to doxorubicin (DOX) in advanced soft tissue sarcoma (STS): A retrospective analysis of the EORTC-Soft Tissue and Bone Sarcoma Group database. (2015) (0)
- ASO Author Reflections: Extraskeletal Myxoid Chondrosarcoma: A Rare Sarcoma Associated With Prolonged Survival (2020) (0)
- Peritonectomy and Intraperitoneal Hypertermic Perfusion in the Treatment of Pseudomixoma Peritonei (Pmp) (2002) (0)
- Adjuvant chemotherapy in high-risk liposarcomas. (2016) (0)
- Lapatinib in advanced chordoma: A phase II study. (2012) (0)
- OC-0070 Radiation Therapy for Retroperitoneal Liposarcoma – A report from TARPSWG (2019) (0)
- Extraskeletal Myxoid Chondrosarcoma (2020) (0)
- So Now What? Unanswered Questions Regarding Retroperitoneal Sarcomas, Hospital Volume, Multidisciplinary Expertise, and Outcomes (2022) (0)
- Advanced epithelioid haemangioendotelioma: Fever, pain, and pleural effusion predict a worse outcome. (2019) (0)
- NIRO or No-go? Positioning a Novel Systemic Treatment Option for Desmoid Tumours (2023) (0)
- Volume-Outcome Relationship in Surgery of Soft Tissue Sarcomas (2020) (0)
- 3439 Prognostic factors in soft tissue sarcoma patients with lung metastases only receiving first-line chemotherapy. An exploratory, retrospective analysis on fifteen trials of the European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) (2015) (0)
- Gastrointestinal Stromal Tumors (GISTs): Molecular Analysis of KIT/PDGFRA/BRAF Genes Refines Risk Assessment (Register Study) (2013) (0)
- Prehabilitation in retroperitoneal sarcoma (RPS): Efficacy in reverting tumor-related malnutrition and effect on surgical outcome (2023) (0)
- Radiotherapy in Retroperitoneal Liposarcoma: Are We Looking for an Answer in the Wrong Place? (2022) (0)
- Contemporary role of amputation for patients with extremity soft tissue sarcoma. (2022) (0)
- Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma (2009) (0)
- Desmoid fibromatosis and pregnancy: A multi-institutional analysis of recurrence and obstetric risk. (2012) (0)
- Epitheliod hemagioendothelioma (EHE) patient-derived model (PDX): Drug activity assessment and validation of novel biomarkers. (2022) (0)
- Tenosynovial giant cell tumor (TGCT)/pigmented villonodular synovitis (PVNS): Outcome of 313 patients before the era of kinase inhibitors. (2012) (0)
- Peri-operative Therapies for Localized Retroperitoneal Soft Tissue Sarcoma (2012) (0)
- ASO Video Abstract: Delayed Gastric Emptying After Multivisceral Resection for Retroperitoneal Sarcoma (2022) (0)
- Inoperable Primary Retroperitoneal Sarcoma: Clinical Characteristics And Reasons Against Resection At A Single Referral Institution (2020) (0)
- 1546P Therapeutic strategies for uterine PEComas (2021) (0)
- Recurrent neck myxofibrosarcoma: a case report (2021) (0)
- Abstract A17: Mode of action of trabectedin in myxoid liposarcomas. (2011) (0)
- Desmoplastic small round cell tumor: A series of patients surgically treated at a single institution. (2021) (0)
- ASO Visual Abstract: Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients (2022) (0)
- Malignancy grade and immunohistochemical myogenic/rhabdomyoblastic differentiation as an outcome determinant in retroperitoneal liposarcoma. (2014) (0)
- P02Human equilibrative nucleoside transporter 1 as a predictor of efficacy to gemcitabine in advanced leiomyosarcoma and angiosarcoma (2016) (0)
- ASO Author Reflections: Organ Infiltration in Retroperitoneal Liposarcomas: A Novel Prognostic Factor? (2023) (0)
- Corrigendum to 'Chemotherapy in patients with localized angiosarcoma of any site: A retrospective european study' [Eur J Cancer 171 (2022) 183-192]. (2023) (0)
- Is CTNNB1 mutational analysis predictive for progression in patients with sporadic desmoid tumors primarily observed (2012) (0)
- Management of complicated tumor response (CTR) to tyrosine kinase inhibitors (TKI) in gastrointestinal stromal tumor (GIST) patients (pts) with locally advanced/metastatic disease. (2016) (0)
- Long term outcome of complex surgical resection and reconstruction for rare thoracic cancers. (2023) (0)
- Role of adjuvant imatinib dose in radically resected GIST harboring KIT exon 9 mutations. (2020) (0)
- Acknowledgment of Reviewers 2021. (2021) (0)
- The prognostic impact of unplanned excision in primary STS of the extremities and trunk wall: Is re-excision always mandatory? (2020) (0)
- 278 Myxoid liposarcoma tumors with different chimera subtypes xenografted in nude mice are characterized by different response to trabectedin and gene expression profile (2010) (0)
- 590 A dose dense schedule improves antitumor activity of trabectedin in myxoid liposarcoma with type III FUS-CHOP chimera (2014) (0)
- Extremity soft tissue sarcoma: The need for a differential surgical approach to primary tumor and local recurrence? (2006) (0)
- Working to improve the management of sarcoma patients across Europe: a policy checklist (2018) (0)
- Malignant peripheral nerve sheath tumors (MPNST) of the retroperitoneum and pelvis: prognostic factors and outcome in a series of patients treated at a single institution (2020) (0)
- UNDERESTIMATED PROTEIN ENERGETIC MALNUTRITION (PEM) IN PATIENTS AFFECTED BY RETROPERITONEAL SARCOMA (RPS) (2019) (0)
- Soft tissue tumors (STT) of the adult: Dynamic contrast enhanced (DCE) MR imaging evaluation (2010) (0)
- 65. A multicenter experience of TNF-αa and melphalan based isolated limb perfusion in patients with locally advanced extremity desmoid tumours (2014) (0)
- Prognostic role of % changes in longest tumor diameter (LTD) in localized high-risk soft tissue sarcoma (STS) treated with neoadjuvant chemotherapy in a randomized clinical trial. (2020) (0)
- ASO Author Reflections: Outcome Improvement Over Time in Extremity and Trunk Wall Soft Tissue Sarcomas: To Whom the Merit? (2022) (0)
- OP-ANNO180096 51..67 (2018) (0)
- Reverse bilateral latissimus dorsi flap reconstruction after extensive mid back dermatofibrosarcoma protuberans excision: a case report (2018) (0)
- Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group (2022) (0)
- OC-0271 First randomized study of Hafnium nanoparticles activated by radiotherapy in soft tissue sarcoma (2019) (0)
- Postoperative morbidity and mortality in a large series of primary retroperitoneal sarcoma (RPS) treated at 8 tertiary centers: A study from the Transatlantic RPS Working Group. (2015) (0)
- Myxoid Liposarcoma (2020) (0)
- ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) (2021) (0)
- Reviewer Acknowledgment 2015 (2016) (0)
- Abstract 1086: CTNNB1-mutated desmoid tumors have different gene expression patterns compared to wild-type ones (2015) (0)
- Gastrointestinal Stromal Tumor (2015) (0)
- EP-1686: Hafnium oxide nanoparticles and radiotherapy for solid tumors: a promising new treatment strategy (2018) (0)
- Limb salvage for soft tissue sarcoma: multimodal procedures or improved surgery? (1999) (0)
- ASO Visual Abstract: The Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma (RPS) (2022) (0)
- Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas: An International Study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. (2022) (0)
- Major Amputations for Primary Extremity Soft Tissue Sarcoma: Rate and Indications at a Referral Center in Recent Years. (2020) (0)
- Quality o f S urgery a nd O utcome i n E xtra-Abdominal Aggressive F ibromatosis: A S eries o f P atients S urgically Treated a t a S ingle I nstitution (2003) (0)
- The Effect of Systemic Treatment on Patient Survival of Soft-tissue Sarcoma (2008) (0)
- Soft Tissue Tumors of the Groin and Inguinal Region (2018) (0)
- Issue Information ‐ TOC (2020) (0)
- Trabectedin with concurrent low-dose of radiation therapy for metastatic soft tissue sarcomas: A phase II trial of Spanish, French and Italian sarcoma groups (2019) (0)
- Reply to Deleterious effect of ifosfamide in leiomyosarcoma: Convergence of weak signals (2020) (0)
- Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation (2021) (0)
- Trabectedin (T) in desmoplastic small round cell tumor (DSRCT): Report of its effect in 3 relapsed patients (pts) and the comparison of different regimens in a patient-derived xenograft (PDX) model. (2021) (0)
- Towards a Global Collaboration: the Trans-Atlantic Retroperitoneal Sarcoma Working Group (2019) (0)
- Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin (2019) (0)
- Collaborations Between SSO and the Connective Tissue Oncology Society (CTOS) Series (2015) (0)
- Staging systems and nomograms (2019) (0)
- Correction to: Effect of Preoperative Treatment on the Performance of Predictive Nomograms in Primary Retroperitoneal Sarcoma (2022) (0)
- ASO Visual Abstract: Refining the Approach to Patients with Primary Soft Tissue Sarcoma of the Extremities and Trunk Wall—Outcome Improvement over Time at a Single Institution (2022) (0)
- 3404 External validation of a nomogram predicting disease-free (DFS) and overall survival (OS) in patients (pts) with primary retroperitoneal sarcoma (pRPS) (2015) (0)
- The role of surgery after Imatinib therapy in GIST (2013) (0)
- Correction: Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin (2020) (0)
- ASO Author Reflections: Understanding the Impact of Primary Retroperitoneal Sarcoma Resection on Patient Well-being: One Step Forward in Learning How Caring for Patients is as Important as Curing Their Cancers (2020) (0)
- First and further-line multidisciplinary treatment of retroperitoneal sarcomas (2022) (0)
- Traditional risk scores do not properly predict perioperative morbidity and mortality for retroperitoneal sarcoma resection (2022) (0)
- Correction to: Global Forum of Cancer Surgeons: Position Statement to Promote Cancer Surgery Globally (2021) (0)
- Response to radiation therapy in solitary fibrous tumor/hemangiopericytoma. (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alessandro Gronchi?
Alessandro Gronchi is affiliated with the following schools:
